X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5726) 5726
Publication (270) 270
Book Review (120) 120
Book Chapter (77) 77
Book / eBook (35) 35
Conference Proceeding (7) 7
Dissertation (4) 4
Newspaper Article (4) 4
Reference (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4447) 4447
male (2848) 2848
index medicus (2514) 2514
female (2332) 2332
surgery (1929) 1929
middle aged (1904) 1904
aged (1770) 1770
cardiac & cardiovascular systems (1702) 1702
treatment outcome (1618) 1618
peripheral vascular disease (1198) 1198
stents (1186) 1186
animals (1122) 1122
time factors (888) 888
adult (836) 836
graft occlusion, vascular - etiology (809) 809
risk factors (792) 792
follow-up studies (786) 786
coronary artery bypass (768) 768
graft occlusion, vascular - prevention & control (715) 715
retrospective studies (705) 705
transplantation (677) 677
blood vessel prosthesis (610) 610
aged, 80 and over (589) 589
angioplasty (583) 583
graft occlusion, vascular - therapy (567) 567
drug-eluting stents (529) 529
stent (529) 529
vascular patency (518) 518
thrombosis (504) 504
graft occlusion, vascular - drug therapy (491) 491
coronary angiography (479) 479
graft occlusion, vascular - diagnostic imaging (471) 471
cardiology (441) 441
analysis (437) 437
care and treatment (429) 429
saphenous vein - transplantation (429) 429
prospective studies (418) 418
percutaneous coronary intervention (414) 414
prosthesis design (411) 411
radiology, nuclear medicine & medical imaging (408) 408
restenosis (408) 408
health aspects (402) 402
grafts (401) 401
medicine & public health (372) 372
mortality (366) 366
cardiology and cardiovascular medicine (365) 365
disease (347) 347
abridged index medicus (339) 339
therapy (339) 339
ischemia (334) 334
respiratory system (323) 323
blood vessel prosthesis implantation - adverse effects (319) 319
cardiovascular (312) 312
graft occlusion, vascular - physiopathology (310) 310
balloon angioplasty (308) 308
follow-up (306) 306
outcomes (303) 303
implantation (294) 294
management (292) 292
risk assessment (288) 288
stenosis (287) 287
platelet aggregation inhibitors - therapeutic use (284) 284
medicine (281) 281
trial (277) 277
rats (276) 276
patients (273) 273
coronary artery bypass - adverse effects (268) 268
graft survival (266) 266
reoperation (263) 263
experience (262) 262
polytetrafluoroethylene (262) 262
complications (248) 248
coronary vessels (247) 247
aneurysms (246) 246
blood vessel prosthesis implantation - instrumentation (245) 245
transluminal angioplasty (244) 244
recurrence (243) 243
graft occlusion, vascular - diagnosis (242) 242
atherosclerosis (241) 241
heart (239) 239
renal dialysis (237) 237
angiography (234) 234
heart attacks (230) 230
prevention (230) 230
coronary artery disease - surgery (228) 228
disease models, animal (227) 227
graft rejection (226) 226
angioplasty, balloon, coronary (224) 224
revascularization (222) 222
cardiac patients (216) 216
leg - blood supply (214) 214
graft occlusion, vascular - pathology (213) 213
stents - adverse effects (213) 213
survival (213) 213
graft occlusion, vascular - surgery (212) 212
graft (207) 207
graft occlusion, vascular - epidemiology (206) 206
research (206) 206
coronary heart disease (203) 203
thrombolytic therapy (203) 203
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5756) 5756
German (37) 37
French (14) 14
Russian (8) 8
Spanish (7) 7
Chinese (4) 4
Polish (3) 3
Czech (2) 2
Italian (2) 2
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Japanese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 95 - 102
Background Proton pump inhibitors (PPIs) are frequently prescribed in combination with clopidogrel, but conflicting data exist as to whether PPIs diminish the... 
Cardiovascular | LANSOPRAZOLE | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | CARDIOVASCULAR EVENTS | PREVENTION | OMEPRAZOLE | Follow-Up Studies | Humans | Middle Aged | Male | Aspirin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Hyperplasia - drug therapy | Drug Therapy, Combination | Myocardial Infarction - diagnosis | Myocardial Infarction - surgery | Coronary Vessels - drug effects | Coronary Vessels - pathology | Administration, Oral | Treatment Outcome | Ticlopidine - analogs & derivatives | Hyperplasia - etiology | Hyperplasia - pathology | Tunica Intima - drug effects | Graft Occlusion, Vascular - etiology | Tunica Intima - pathology | Graft Occlusion, Vascular - pathology | Graft Occlusion, Vascular - drug therapy | Coronary Vessels - surgery | Aged | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Care and treatment | Cardiac patients | Patient outcomes | Clinical trials | Proton pump inhibitors | Stent (Surgery) | Studies | Consortia | Heart attacks | Coronary vessels | Classification | Prodigies | Metabolism | Multivariate analysis | Stents | Clinical outcomes
Journal Article
Journal Article
European Journal of Vascular & Endovascular Surgery, ISSN 1078-5884, 2017, Volume 53, Issue 6, pp. 853 - 861
Objectives The purpose was to study long-term outcome after thrombolysis for acute arterial lower limb ischaemia, and to evaluate the results depending on the... 
Surgery | Long-term follow-up | Long-term outcome | Thrombolysis | Aetiological subgroups | Acute limb ischaemia | Amputation free survival | SURGERY | VALIDATION | INITIAL TREATMENT | SURGICAL REVASCULARIZATION | THERAPY | PERIPHERAL VASCULAR DISEASE | INTRAARTERIAL THROMBOLYSIS | ANEURYSM | OCCLUSION | UROKINASE | Graft Occlusion, Vascular - diagnostic imaging | Humans | Male | Aneurysm - physiopathology | Aneurysm - drug therapy | Embolism - physiopathology | Embolism - drug therapy | Thrombosis - diagnostic imaging | Fibrinolytic Agents - adverse effects | Sweden | Time Factors | Female | Retrospective Studies | Aneurysm - diagnostic imaging | Databases, Factual | Ischemia - diagnostic imaging | Thrombosis - physiopathology | Peripheral Arterial Disease - drug therapy | Treatment Outcome | Ischemia - physiopathology | Embolism - diagnostic imaging | Peripheral Arterial Disease - physiopathology | Ischemia - drug therapy | Graft Occlusion, Vascular - drug therapy | Peripheral Arterial Disease - diagnostic imaging | Aged | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Thrombolytic Therapy - adverse effects | Lower Extremity - blood supply | Graft Occlusion, Vascular - physiopathology | Vascular Patency | Ischemia | Medicine, Experimental | Medical research | Blood circulation disorders | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Kirurgi | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems
Journal Article
Heart, ISSN 1355-6037, 05/2012, Volume 98, Issue 9, pp. 706 - 711
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 06/2012, Volume 10, Issue 6, pp. 985 - 991
Background:  Current treatment of acute peripheral artery or bypass graft occlusion utilizes catheter‐directed thrombolysis of a plasminogen activator (PA).... 
peripheral arterial occlusion | thrombolysis | bypass graft occlusion | plasmin | Bypass graft occlusion | Peripheral arterial occlusion | Thrombolysis | Plasmin | SURGERY | INITIAL TREATMENT | ISCHEMIA | RANDOMIZED TRIAL | ACTIVATOR | PERIPHERAL ARTERIAL | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | THROMBOLYTIC THERAPY | ALFIMEPRASE | FIBRINOGEN | UROKINASE | Arterial Occlusive Diseases - blood | Graft Occlusion, Vascular - diagnostic imaging | United States | Humans | Middle Aged | Fibrinolysin - administration & dosage | Male | Dose-Response Relationship, Drug | Young Adult | Fibrinolytic Agents - adverse effects | Time Factors | Thrombolytic Therapy - methods | Aged, 80 and over | Brazil | Adult | Female | Catheterization, Peripheral - adverse effects | alpha-2-Antiplasmin - metabolism | Acute Disease | Europe | Arterial Occlusive Diseases - diagnostic imaging | Treatment Outcome | Biomarkers - blood | Fibrinolysin - adverse effects | Radiography | alpha-Macroglobulins - metabolism | Arterial Occlusive Diseases - drug therapy | Graft Occlusion, Vascular - drug therapy | Adolescent | Fibrinogen - metabolism | South Africa | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Lower Extremity - blood supply | Graft Occlusion, Vascular - blood | Infusions, Intra-Arterial
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 9, pp. 1069 - 1077
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2010, Volume 51, Issue 3, pp. 600 - 609
Purpose To investigate the safety and effectiveness of a novel thrombolytic, alfimeprase, in catheter-directed thrombolysis (CDT) of acute peripheral arterial... 
Surgery | SURGERY | REVASCULARIZATION | LOWER-EXTREMITY | PROSPECTIVE RANDOMIZED TRIAL | INITIAL TREATMENT | THROMBOLYSIS | ISCHEMIA | PERIPHERAL VASCULAR DISEASE | Blood Pressure | Graft Occlusion, Vascular - diagnostic imaging | United States | Humans | Middle Aged | Male | Metalloendopeptidases - adverse effects | Young Adult | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Adult | Ankle - blood supply | Brachial Artery - physiopathology | Female | Arterial Occlusive Diseases - physiopathology | Odds Ratio | Length of Stay | Graft Occlusion, Vascular - complications | Acute Disease | Double-Blind Method | Risk Assessment | Placebo Effect | Intermittent Claudication - etiology | Arterial Occlusive Diseases - diagnostic imaging | Treatment Outcome | Metalloendopeptidases - administration & dosage | Catheterization, Peripheral | Pulse Therapy, Drug | Regional Blood Flow | Radiography | Arterial Occlusive Diseases - drug therapy | Graft Occlusion, Vascular - drug therapy | Arterial Occlusive Diseases - surgery | Vascular Surgical Procedures | Aged | Fibrinolytic Agents - administration & dosage | Arterial Occlusive Diseases - complications | Graft Occlusion, Vascular - surgery | Pain Measurement | Thrombolytic Therapy - adverse effects | Graft Occlusion, Vascular - physiopathology | Infusions, Intra-Arterial
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2011, Volume 54, Issue 5, pp. 1339 - 1344
Journal Article